|
|
| Phases of Development | Preclinical | Phase I | Phase I/II | Phase II | Phase III | Approved | Marketed |
|---|
| Cancer | 4 | 4 | 1 | 0 | 1 | 0 | 2 | | Endocrine / Metabolic | 0 | 0 | 0 | 0 | 0 | 1 | 6 | | Genitourinary | 0 | 0 | 0 | 0 | 1 | 0 | 2 | | Musculoskeletal | 1 | 2 | 0 | 0 | 1 | 0 | 0 | | Neurology | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
|
|
Products Targeting Androgen receptor